Myriam Badr

Myriam Badr is currently working as a Sr. Business Development Manager at Quantoom Biosciences, focusing on removing barriers to manufacturing mRNA vaccines and therapeutics. Prior to this role, Myriam held positions at Sartorius and NanoTemper Technologies in technical sales and sales application scientist roles. Myriam's academic background includes a PhD in Molecular Biophysics from Florida State University and a Bachelor of Science in Biology from the American University of Beirut. Myriam previously conducted postdoctoral research at Rutgers University on the cellular mechanisms of Duchenne Muscular Dystrophy and worked as a Research Assistant at Florida State University on developing a Ca2+ dependent FRET Troponin C.